Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients

Blood Cancer Journal · Published 2026-06-24 · DOI 10.1038/s41408-026-01549-0

Free full text

Authors (28)

Niels W. C. J. van de Donk, Fredrik Schjesvold, Bronno van der Holt, Monique C. Minnema, Ka Lung Wu, Annemiek Broijl, Wilfried W. H. Roeloffzen, Alain Gadisseur, Giuseppe Pietrantuono, Ludek Pour, Vincent H. J. van der Velden, Thomas Lund, Massimo Offidani, Sara Bringhen, Luisa Giaccone, Wida Razawy, Paola Tacchetti, Katia Mancuso, Trine Silkjaer, Jo Caers, Sonja Zweegman, Roman Hájek, Reuben Benjamin, Annette Juul Vangsted, Mario Boccadoro, Francesca Gay, Pieter Sonneveld, Pellegrino Musto

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2026

Citation

Donk, N., Schjesvold, F., Holt, B., et al. (2026). Long-term follow-up of the transplant-eligible cohort of the EMN12/HOVON-129 study for primary plasma cell leukemia patients. Blood Cancer Journal. https://doi.org/10.1038/s41408-026-01549-0

Related articles